Lakefront Biotherapeutics NV
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $320.5M |
| FY2019 | — | — | $656.9M |
| FY2021 | — | — | $807.9M |
| FY2022 | — | — | $97.3M |
| FY2023 | — | — | $34.5M |
| FY2024 | — | — | $40.3M |
| FY2025 | — | — | $40.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $320.5M |
| FY2019 | — | — | $656.9M |
| FY2021 | — | — | $807.9M |
| FY2022 | — | — | $97.3M |
| FY2023 | — | — | $34.5M |
| FY2024 | — | — | $40.3M |
| FY2025 | — | — | $40.0M |